Nomura Holdings
MRNA icon

Nomura Holdings’s Moderna MRNA Stock Holding History

Nomura Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
45,437
+4,894
+12% +$253K ﹤0.01% 936
2026
Q1 		$2.06M Buy
40,543
+6,074
+18% +$283K 0.01% 918
2025
Q4 		$1.02M Sell
34,469
-72,696
-68% -$1.98M ﹤0.01% 1331
2025
Q3 		$2.77M Buy
107,165
+99,029
+1,217% +$2.76M ﹤0.01% 1013
2025
Q2 		$224K Sell
8,136
-22,690
-74% -$598K ﹤0.01% 1285
2025
Q1 		$874K Buy
30,826
+15,938
+107% +$566K ﹤0.01% 1326
2024
Q4 		$619K Sell
14,888
-37,118
-71% -$1.77M ﹤0.01% 1703
2024
Q3 		$3.48M Sell
52,006
-83,125
-62% -$7.63M 0.01% 776
2024
Q2 		$16M Buy
135,131
+132,244
+4,581% +$16.7M 0.03% 321
2024
Q1 		$308K Sell
2,887
-13,452
-82% -$1.36M ﹤0.01% 1356
2023
Q4 		$1.62M Sell
16,339
-5,298
-24% -$446K ﹤0.01% 1029
2023
Q3 		$2.23M Buy
21,637
+6,649
+44% +$742K 0.01% 761
2023
Q2 		$1.82M Buy
14,988
+10,305
+220% +$1.37M ﹤0.01% 737
2023
Q1 		$719K Buy
+4,683
New +$773K ﹤0.01% 1081
2022
Q4 		– Sell
-23,247
Closed -$2.76M – 1611
2022
Q3 		$2.76M Sell
23,247
-4,435
-16% -$673K 0.01% 728
2022
Q2 		$4.13M Sell
27,682
-2,219
-7% -$317K 0.01% 607
2022
Q1 		$5.29M Buy
29,901
+1,906
+7% +$321K 0.02% 594
2021
Q4 		$7.06M Buy
27,995
+9,505
+51% +$2.78M 0.02% 587
2021
Q3 		$6.33M Sell
18,490
-42,970
-70% -$15.8M 0.02% 553
2021
Q2 		$14.5M Buy
+61,460
New +$11M 0.04% 282
2021
Q1 		– Sell
-98,268
Closed -$10.3M – 2153
2020
Q4 		$10.3M Buy
98,268
+96,768
+6,451% +$9.79M 0.02% 418
2020
Q3 		$106K Buy
+1,500
New +$105K ﹤0.01% 1208
2019
Q4 		– Sell
-18,000
Closed -$267K – 1255
2019
Q3 		$267K Buy
+18,000
New +$266K ﹤0.01% 1049

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Nomura Holdings's MRNA Position: Q2 2026 in Review

Nomura Holdings increased its Moderna (MRNA) stake by 12% in Q2 2026, buying an estimated $253K and bringing the position to 45,437 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Nomura Holdings first reported a position in MRNA in Q3 2019 and has held it in 23 quarters since. The position peaked at $16M in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Nomura Holdings held 45,437 shares of Moderna worth $3.18M as of Q2 2026.
  • Nomura Holdings bought 4,894 Moderna shares in Q2 2026, an estimated $253K.
  • Moderna made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #936 holding.
  • Nomura Holdings first reported a position in Moderna in Q3 2019 and has held it in 23 quarters since.
  • Nomura Holdings's Moderna position peaked at $16M in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.